Table 1.
Number of reported cases | Age at diagnosis | Laterality / size of ovarian tumor | Histological type of mucinous ovarian tumor | Immunohistochemical profile of mucinous ovarian tumor | Percentage and composition of teratomatous elements | Appendix examination | Therapeutic strategy | Follow-up data | Bibliographical reference |
---|---|---|---|---|---|---|---|---|---|
3 | 35 | right / 22 cm | borderline with focal cystadenocarcinoma | CK7-, CK20+ | 4%, squamous epithelium and adnexal glands | Ma and Mi: normal | cytoreductive surgery | death after disease progresion at 49 mo | [28] Ronnett et al. Am J Surg Pathol. 2003. |
81 | left / 7 cm | cystadenoma | CK7-, CK20+ | 8%, squamous epithelium and sebaceous glands | Ma and Mi: normal | cytoreductive surgery | survival without relapse at 54 mo | ||
89 | left / 15 cm | borderline | CK7-, CK20+ | 11%, squamous epithelium and cartilage | Ma and Mi: normal | cytoreductive surgery | survival without relapse at 48 mo | ||
1 | 39 | left / 14 cm | cystadenoma | CK7-, CK20+ | low, squamous epithelium and adnexal glands | Ma and Mi: normal | cytoreductive surgery | survival without relapse at 6 mo | [29] Pranesh et al. J Clin Pathol. 2005. |
1 | 67 | left / 20 cm | borderline | CK7-, CK20+ | low, dermoid cyst | NA (appendicectomy 42 years ago) | cytoreductive surgery | survival without relapse at 6 mo | [30] Marquette et al. Int J Gynecol Pathol. 2006. |
2 | 38 | left / 14 cm | borderline | CK7-, CK20+ | 5–10%, squamous epithelium and adnexal glands | Ma and Mi: normal | cytoreductive surgery | survival without relapse at 24 mo | [31] Stewart et al. Pathology. 2006. |
58 | right / 16.5 cm | borderline | CK7-, CK20+ | 5–10%, squamous epithelium and adnexal glands | Ma and Mi: normal | cytoreductive surgery | survival without relapse at 21 mo | ||
1 | 45 | left / 12 cm | cystadenocarcinoma | NA | low, squamous epithelial and sebaceous glands | Ma and Mi: normal | cytoreductive surgery | NA | [32] Mandal et al. Arch Gynecol Obstet. 2008. |
10 | 57 | NA / NA | cystadenoma | CK7-, CK20+ (88%) CK7+, CK20- (13%) | low, squamous epithelium and adnexal glands, more or less other mature tissues | Ma and Mi: normal | cytoreductive surgery | NA | [33] McKenney et al. Am J Surg Pathol. 2008. |
36 | NA / 25 cm | borderline | Ma and Mi: normal | NA | |||||
54 | NA / 14 cm | borderline | Ma and Mi: normal | survival without relapse at 24 mo | |||||
41 | NA / 25 cm | borderline | NA | NA | |||||
42 | NA / 7 cm | borderline | Ma and Mi: normal | survival without relapse at 27 mo | |||||
47 | NA / 20 cm | borderline | Ma and Mi: normal | survival without relapse at 23 mo | |||||
28 | NA / 22 cm | borderline | Ma and Mi: normal | survival without relapse at 61 mo | |||||
48 | NA / NA | cystadenocarcinoma | NA | metastases to omentum and pelvic serosa at 29 mo | |||||
21 | NA / NA | cystadenocarcinoma | NA | died of other disease at 6 mo | |||||
56 | NA / NA | cystadenocarcinoma | Ma and Mi: normal | metastases to omentum, small bowel serosa and mesentery at diagnosis | |||||
2 | 46 | right / 15 cm | borderline | CK7+, CK20+ | NA, squamous epithelium and bone | Ma and Mi: normal | cytoreductive surgery | NA | [34] Hwang et al. Int J Gynecol Pathol. 2009. |
28 | left / 40 cm | cystadenoma focally borderline | NA, squamous epithelium and adnexa | Ma without Mi: normal | cytoreductive surgery and adjuvant chemotherapy | NA | |||
1 | 43 | right / NA | borderline | CK7+, CK20- | NA, squamous epithelium | Ma and Mi: chronic appendicitis | cytoreductive surgery | survival without relapse at 6 mo | [35] Mohtaram et al. Pan Afr Med J. 2013. |
1 | 45 | right / 29 cm | borderline | CK7+, CK20- | skin and adnexa | Ma and Mi: normal | cytoreductive surgery | NA | [36] Choi et al. Pathology. 2016. |
3 | 75 | left / NA | borderline | CK7+, CK20+ | NA | Ma and Mi: appendicitis | cytoreductive surgery | survival without relapse at 25 mo | [37] Yan et al. Cancer Manag Res. 2020. |
45 | right / NA | borderline with focal cystadenocarcinoma | CK7+, CK20+ | NA | Ma and Mi: appendicitis | cytoreductive surgery and HIPEC | survival with disease at 30 mo | ||
53 | bilateral / NA | cystadenocarcinoma | CK7-, CK20+ | NA | Ma and Mi: appendicitis | cytoreductive surgery and HIPEC | survival with disease at 29 mo | ||
1 | 25 | left / 8.4 cm | ruptured appendiceal-like mucocele associated with LAMN in an ovarian teratoma | CK7+, CK20+ | skin and pilosebaceous annexes, serous and mucinous glands, respiratory epithelium, adipose tissue and smooth muscle and colonic wall | Ma and Mi: normal | cytoreductive surgery | survival without relapse at 5 mo | Present case report |
total: 26 cases | mean age at diagnosis: 47.8 |
Ma macroscopic, Mi microscopic, mo months, NA Not Available, HIPEC Hyperthermic IntraPEritoneal Chemotherapy
Cytoreductive surgery relying on hysterectomy, bilateral salpingo-oophorectomy, appendicectomy and omentectomy